Infliximab
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20132 publications
Life-threatening multisystem sarcoidosis with neurological, renal, ocular and autoimmune haemolytic manifestations treated with intravenous immunoglobulin, plasma exchange, cyclophosphamide and infliximab.
Journal: BMJ case reports
Published: September 04, 2026
Switchback from biosimilar tumor necrosis factor-alpha inhibitors to reference medicines: a review.
Journal: Expert review of clinical immunology
Published: September 03, 2026
Infliximab for the Treatment of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 29, 2026
Nationwide Trends and Cost Implications of Switching Between Infliximab Products.
Journal: The American journal of managed care
Published: August 28, 2026
Concurrent Immune-related Enteritis and Cytomegalovirus Enteritis during Immune Checkpoint Inhibitor Therapy.
Journal: Internal medicine (Tokyo, Japan)
Published: August 26, 2026
Patient-Level Risk Characterization of Drug-Associated Hidradenitis Suppurativa Using Machine Learning.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
Immune Checkpoint Inhibitor-Related Gastrointestinal Toxicity: Pathogenesis, Diagnosis, and Management.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: August 17, 2026
Longitudinal transcriptomic analysis of mucosa in ulcerative colitis after anti-tumor necrosis factor withdrawal compared to continued treatment.
Journal: Journal of Crohn's & colitis
Published: August 12, 2026
Surgical Outcomes for Hidradenitis Suppurativa: Does Biologic Therapy Make a Difference?
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: August 12, 2026
Comparison of the Risk of Acute Anterior Uveitis Flare Between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: August 11, 2026
Two case reports of medication-induced elkonyxis in adolescents and literature review.
Journal: JAAD case reports
Published: August 08, 2026
Last Updated: 09/19/2026